Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
May 07 (Reuters) - Spago Nanomedical Q1 operating expenses SEK -7.967 million. Q1 adjusted EPS SEK -0.01 Q1 net income SEK -6.798 million
May 07 (Reuters) - Spago Nanomedical Q1 operating expenses SEK -7.967 million. Q1 adjusted EPS SEK -0.01 Q1 net income SEK -6.798 million